Dan Dowd


Chief Clinical Officer

Dr. Daniel Dowd is Genomind’s Chief Clinical Officer. His responsibilities at Genomind include building and managing a mental health medical affairs team of PharmDs and PhDs. Dr. Dowd is also intimately involved with product development, genetic research, medical education programs and pharmacy integrations.

He is a PharmD licensed in New York and New Jersey and has over 15 years of unique experience across community pharmacy management, medical affairs and healthcare education. Prior to joining Genomind, Dr. Dowd held positions as district and regional director of community pharmacy training and operations for several pharmacies including Rite Aid and A&P. For 13 years, he also developed and taught advanced pharmacology courses at the City University of New York (CUNY). Dr. Dowd has published on the implementation of pharmacogenetics in psychiatry and has been interviewed by national media outlets, including Drug Topics, JAMA Medical News and Perspectives and the Dr. Oz show. He is a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the American Society of Pharmacovigilance STRIPE Collaborative Community.

Dr. Dowd earned his PharmD from the Rutgers Ernest Mario School of Pharmacy, following completion of his BS Biology degree from SUNY Binghamton.